Company Overview

Business Description

Sector
Health Care
Industry
Health Care
Headquarters
Netherlands NL
Employees
137
IPO date
Oct 21, 2021

ONWARD Medical develops implantable and external neurostimulation devices that are designed to help people with spinal cord injury and related movement disorders recover motion and function. Its main products are built around electrical stimulation of the spinal cord, which aims to activate nerve pathways that still exist but no longer work properly after injury. The company focuses on therapies that can support walking, hand use, blood pressure control, and other functions affected by spinal cord damage.

The company sells its technology to hospitals, doctors, rehabilitation centers, and research partners, and it also works through clinical programs that support future adoption of its devices. It makes money by selling medical devices and related systems, and by moving its therapies through clinical development toward broader medical use. Its business sits between medical device engineering and neurorehabilitation, which means it is not just making hardware but building a treatment approach around that hardware.

What makes ONWARD’s business different is that it is trying to turn spinal cord stimulation into a practical therapy for daily life, not just a research tool. Instead of treating symptoms with drugs, it uses targeted electrical signals to help the nervous system regain lost function. That puts the company in a specialized corner of the medtech industry where success depends on clinical evidence, physician adoption, and the ability to make complex neurotechnology usable in real care settings.

ONWARD Medical NV Investor Relations

Address
Schimmelt 2
Eindhoven, Noord-Brabant
Netherlands

Business Segments

External therapy systems

This part of ONWARD Medical sells non-invasive ARC therapy systems that deliver stimulation from outside the body to help restore movement and other functions in people with spinal cord injury.

Customers and revenue model

Implantable therapy systems

This part develops and sells implantable ARC systems that are placed in the body and used to deliver targeted stimulation for patients with severe movement and function loss.

Customers and revenue model

Management

Mr. David L. Marver

CEO & Executive Director

Biography unavailable

Dr. Gregoire Courtine Ph.D.

Chief Scientific Officer & Director

Biography unavailable

Mr. Khaled Bahi

Interim Chief Financial Officer

Biography unavailable

Mr. Robert W. Odell

Vice President of Operations

Biography unavailable

Mr. Lorenzo Fanti

Vice President of Legal

Biography unavailable

Mr. Alexandre Casteau

Head of Strategy & Corporate Development

Biography unavailable

Ms. Julie Crom

Director of People & Culture

Biography unavailable

1 / 7